<code id='F0D1CEAC45'></code><style id='F0D1CEAC45'></style>
    • <acronym id='F0D1CEAC45'></acronym>
      <center id='F0D1CEAC45'><center id='F0D1CEAC45'><tfoot id='F0D1CEAC45'></tfoot></center><abbr id='F0D1CEAC45'><dir id='F0D1CEAC45'><tfoot id='F0D1CEAC45'></tfoot><noframes id='F0D1CEAC45'>

    • <optgroup id='F0D1CEAC45'><strike id='F0D1CEAC45'><sup id='F0D1CEAC45'></sup></strike><code id='F0D1CEAC45'></code></optgroup>
        1. <b id='F0D1CEAC45'><label id='F0D1CEAC45'><select id='F0D1CEAC45'><dt id='F0D1CEAC45'><span id='F0D1CEAC45'></span></dt></select></label></b><u id='F0D1CEAC45'></u>
          <i id='F0D1CEAC45'><strike id='F0D1CEAC45'><tt id='F0D1CEAC45'><pre id='F0D1CEAC45'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:978
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Biohaven protein
          Biohaven protein

          SpencerPlatt/GettyImagesBiohavenPharmaceuticalssaidWednesdaythatanewtypeofexperimentalmedicinereduce

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          iTeos Therapeutics debuts first data on TIGIT

          AdobeITeosTherapeuticsofferedthefirstlookatclinicaldataforitsexperimentalcancerantibodythatworksbybl